Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 15 of 15 for “"Oncotype DX"”.
-
The effect of menstrual cycling on genomic predictive biomarkers in premenopausal breast cancer
… to treatment. A leading genomic assay is Oncotype DX, which quantifies a panel of 21 genes to calculate a Recurrence Score. The Oncotype DX 21-gene Recurrence Score is predictive of adjuvant chemotherapy benefit for women with early-stage, hormone receptor (HR)-positive, HER2-negative …
-
Studie zur Bestimmung des Einflusses von Oncotype DX® auf die Entscheidung für oder gegen eine adjuvante Chemotherapie bei Patientinnen mit Hormonrezeptor positivem Mammakarzinom in Deutschland
… eine prospektive Studie, welche den Einfluss des Oncotype DX® auf die Therapieentscheidung für oder gegen eine Chemotherapie untersucht und die erste Studie, welche über prospektive Daten über den Einsatz einer Genexpressionsanalyse bei Frauen mit nodalpositivem frühen Mammakarzinom in Deutschland …
-
Using Deep Learning and Two-Photon Excitation Fluorescence Microscopy to Predict Breast Cancer Recurrence and Response to Chemotherapy
… for patients. While genomic assays such as the Oncotype DX Recurrence Score offer valuable prognostic information, they are limited in accessibility and application. The work presented in this thesis explores an imaging-based approach for the prediction of breast cancer recurrence that combines …
-
Patch Based Analysis With Machine Learning to Aid Breast Cancer Recurrence Prediction
… model to predict slide level breast cancer Oncotype DX risk category using only H&E-stained images with no additional clinical data or region of interest annotations. Multiple patch size and patch quantity combinations were tested. Patches were extracted from each whole slide image and …
-
Assessing Reproducibility and Value in Genomic Signatures
… based on these genomic signatures (MammaPrint, Oncotype DX, Prosigna) are not part of the standard of care for a patient, and there are many issues in the translation of these discoveries from bench to bedside that hinder their reliable use [24]. These issues range from insufficiently thorough …
-
Οι νεότερες εξελίξεις στον καρκίνο του μαστού-οι αλλαγές στο θεραπευτικό αλγόριθμο
… ήταν η εφαρμογή γονιδιακών αναλύσεων όπως το Oncotype DX, που προβλέπουν τον κίνδυνο υποτροπής σε γυναίκες με πρώιμο HR+/HER2− καρκίνο του μαστού. Επιπλέον, μελέτες όπως οι TAILORx και RxPONDER έδειξαν ότι πολλές γυναίκες, ιδιαίτερα μετεμμηνοπαυσιακές, μπορούν να αποφύγουν τη χημειοθεραπεία. …
-
Gene Expression Analysis in Breast Cancer
… only two prognostic signatures: MammaPrint and Oncotype DX, are currently being validated in clinical trials. Many of these gene expression signatures require independent validation and the underlying biology behind these signatures remains unclear. The aim of this thesis is to identify key …
-
Communicating Results of New Genomic Tests to Physicians
… genomic test for breast cancer recurrence (Oncotype DX) and on two case scenarios, was created. Cognitive interviews with practicing oncologists were conducted to identify problems in the questionnaire. The evaluation involved face-to-face interviews with Kingston oncologists who treat …
-
Evaluating Cost Effectiveness of Precision Cancer Medicine Approaches and The Economic Burden of Colorectal Cancer
… countries. This analysis found that:<br/><br/>1.Oncotype DX® is cost-effective in sparing treatment toxicity.<br/><br/>2.Dihydropyrimidine dehydrogenase gene (DPYD) status testing may be cost-effective to avoid 5-Fluorouracil (5-FU) toxicity.<br/><br/>3.Uridine …
-
Identifying genomic signatures for predicting breast cancer outcomes
… for node-negative primary breast cancer. Oncotype DX is a commercially available gene test for tamoxifen-treated, node-negative, and estrogen receptor-positive breast cancer. These signatures are specific for early stage breast cancers. A population-based approach to the molecular …
-
Biomarcadores para câncer de próstata : da pesquisa à clínica
… urina, estão disponíveis os testes Progensa, ExoDXProstate e Mi Prostate Score Urine Test. Todos esses testes tem potencial para auxiliar no diagnóstico, no sentido de evitar biópsias desnecessárias, mas são utilizados apenas em associação com resultados de exame de toque retal e PSA. Ainda …
-
Evaluation of Prostate Cancer-Associated Factors (SIG27, LINC01089, and FAM84B) and Their Contribution to Prostate Cancer Progression
… possesses predictive power for BCR comparable to Oncotype DX and is strongly associated with immune-related pathways in PC. Sig27 metagene expression is enriched in tumor-associated macrophages (TAMs) and positively correlates with multiple immune checkpoints (ICs), including HAVCR2, TIGIT and …
-
Characterizing The Roles Of Il-11 And Cd68 In Breast Cancer Bone Metastasis
The molecular mechanisms regulating the preferential metastasis of breast cancer to bone have not been fully elucidated, but it is hypothesized that local conditions in the bone create an environment conducive to colonization by breast cancer cells and that the breast cancer cells interact directly …
-
Regression-based deep learning for weakly-supervised cancer biomarker prediction from whole-slide images
… regression framework is applied to predict the Oncotype DX recurrence score (ODXRS), a standard-of-care genomic test for hormone receptor-positive early breast cancer, directly from routine histology slides. The resulting model, Orpheus, demonstrated superior prognostic utility by identifying …
-
Μελέτη και κλινική αξιολόγηση μη κωδικών μορίων RNA (ncRNAs) που στοχεύουν ογκογονίδια στον καρκίνο του μαστού
… μοριακά τεστ για τον καρκίνο του μαστού είναι: Oncotype DX, MammaPrint και uPA/PAI-1. Οι περισσότερες μορφές BrCa αντιμετωπίζονται αρχικά με χειρουργική επέμβαση και ανάλογα με την περίπτωση ακολουθεί χημειοθεραπεία, ορμονοθεραπεία, ακτινοθεραπεία ή συνδυασμός αυτών. Παρά την αποτελεσματικότητα …